Insights Into the Current Management of Older Adults With Type 2 Diabetes in the Ontario Primary Care Setting
| Autor: | Anatoly Langer, Graydon S. Meneilly, Lawrence A. Leiter, Lori MacCallum, Peter Lin, Lori Berard, Lianne Goldin, Alice Y.Y. Cheng, Nahal Nasseri, Ross T. Tsuyuki, Mary K. Tan, Jean-François Yale, Jean-Francois Richard |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Blood Glucose Male medicine.medical_specialty Pediatrics Endocrinology Diabetes and Metabolism Population 030209 endocrinology & metabolism Blood Pressure Type 2 diabetes 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Endocrinology Pharmacotherapy Diabetes mellitus Internal Medicine Medicine Humans Hypoglycemic Agents 030212 general & internal medicine education Depression (differential diagnoses) Glycemic Aged Glycated Hemoglobin Ontario education.field_of_study Primary Health Care business.industry Disease Management General Medicine Middle Aged medicine.disease Blood pressure Cross-Sectional Studies chemistry Diabetes Mellitus Type 2 Practice Guidelines as Topic Physical therapy Female Glycated hemoglobin business |
| Zdroj: | Canadian journal of diabetes. 42(1) |
| ISSN: | 2352-3840 |
| Popis: | Objective The Goal Oriented controL of Diabetes in the Elderly populatioN (GOLDEN) Program assessed the management of older persons with type 2 diabetes in Canadian primary care. Methods Data were extracted from the records of 833 consecutively identified persons 65 years of age or older who had type 2 diabetes and were taking 1 antihyperglycemic agent or more; they were managed by 64 physicians from 36 Ontario clinics. Results More than half (53%) had glycated hemoglobin (A1C) levels of 7.0% or lower, 41% had blood pressure levels below 130/80 mm Hg, and 73% had low-density lipoprotein levels of 2.0 mmol/L or lower; 19% met all 3 criteria. Over the past year, 11% had been assessed for frailty, 16% for cognitive dysfunction and 19% for depression; 88% were referred for eye checkups, and 83% had undergone foot examinations. One-tenth were taking 4 or more antihyperglycemic agents, 87% statins and 52% an angiotensin-converting enzyme inhibitor. More than half of those with high clinical complexity had A1C levels of 7.0% or lower; of these, one-third were taking a sulfonylurea, and one-fifth were taking insulin. In the patients with A1C levels of 7.0% or above and low clinical complexity, there was often no up-titration or initiation of additional antihyperglycemic agents. Conclusions Older persons with type 2 diabetes often have multiple comorbidities. Unlike eye and foot examinations, there was less emphasis on evaluating for frailty, cognitive dysfunction and depression. The GOLDEN patients had generally well-controlled glycemic, blood pressure and cholesterol profiles, but whether these would be reflected in a “sicker” population is not known. Personalized strategies are necessary to avoid undertreatment of “healthy” older patients and overtreatment of the frail elderly. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect